Regular imaging (MRI of the primary site and CT of the chest) every 36 months for the first 23 years post-treatment is recommended due to the high risk of recurrence
Additionally, the FDA label for tirzepatide (Mounjaro, Zepbound) specifically warns that it may decrease the absorption of oral contraceptives, recommending backup contraception during initiation and dose escalation
In summary, these findings [60,83,84,85,89,276] would approach the channel functioning and the BPC 157 counteracting effect, and thereby, in particular, BPC 157 presentation to the essential chain of the events following the application of local anesthetic [285,286]
Abasheva D, Ortiz A, Fernandez-Fernandez B
-Tubulin was used as a loading control